NTI neurotech international limited

News: NTI Neurotech International Says Neurotech Phase II/III Autism Trial Meets Primary Endpoint

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    April 17 (Reuters) - Neurotech International Ltd (NTI) :

    • NEUROTECH PHASE II/III AUTISM TRIAL MEETS PRIMARY ENDPOINT

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.000(0.00%)
Mkt cap ! $13.64M
Open High Low Value Volume
1.3¢ 1.3¢ 1.3¢ $29.45K 2.265M

Buyers (Bids)

No. Vol. Price($)
13 2868143 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 123380 1
View Market Depth
Last trade - 12.25pm 05/09/2025 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.